Nextech Invest
Overview
Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland . They focus almost exclusively on oncology therapeutics and on helping to drive value creation for their portfolio companies . Nextech invests in the most promising drug discovery companies with the potential to create multiple medicines . Their portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Stipple Bio | Apr 2026 | Series A | Lead |
| Atavistik | Mar 2026 | Series B | Co-investor |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Atavistik | Dec 2025 | Series B | Lead |
| Tubulis Technologies | Oct 2025 | Series C | Co-investor |
Key People
Alfred Scheidegger
Founder, Member Of The Board Of Directors
Jakob Loven
Managing Partner
Kanishka Pothula
Managing Partner
Thilo Schroeder
Managing Partner
Melissa McCracken
Partner
Rocco Sgobbo
Partner
Niresh Berinpanathan
Principal
Daniel Michaeli
Biotech Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
